These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1055 related articles for article (PubMed ID: 33778791)

  • 1. Convalescent plasma from people vaccinated after COVID-19 infection.
    Jabal KA; Wiegler KB; Edelstein M
    Lancet Microbe; 2021 May; 2(5):e171-e172. PubMed ID: 33778791
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

  • 3. [COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].
    Richier Q; Hueso T; Tiberghien P; Lacombe K
    Rev Med Interne; 2023 Sep; 44(9):467-471. PubMed ID: 37689526
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 5. Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.
    Ripoll JG; Tulledge-Scheitel SM; Stephenson AA; Ford S; Pike ML; Gorman EK; Hanson SN; Juskewitch JE; Miller AJ; Zaremba S; Ovrom EA; Razonable RR; Ganesh R; Hurt RT; Fischer EN; Derr AN; Eberle MR; Larsen JJ; Carney CM; Theel ES; Parikh SA; Kay NE; Joyner MJ; Senefeld JW
    mBio; 2024 May; 15(5):e0040024. PubMed ID: 38602414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is convalescent plasma an alternative treatment for Covid-19 patients?].
    Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A
    Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent plasma for SARS-CoV-2 infection: win or learn.
    Contreras-Barbeta E; Millan A; Rello J
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34531275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A look-back at convalescent plasma to treat COVID-19.
    Garraud O; Lacombe K; Tiberghien P
    Transfus Apher Sci; 2021 Feb; 60(1):103063. PubMed ID: 33478889
    [No Abstract]   [Full Text] [Related]  

  • 9. Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    Estcourt L; Callum J
    N Engl J Med; 2022 May; 386(18):1753-1754. PubMed ID: 35507487
    [No Abstract]   [Full Text] [Related]  

  • 10. Covid-19 convalescent plasma and SARS-CoV-2 viral variants.
    Joob B; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306. PubMed ID: 34116915
    [No Abstract]   [Full Text] [Related]  

  • 11. Rethinking the role of COVID-19 convalescent plasma in the critically ill.
    Casadevall A; Pirofski LA
    Transfus Apher Sci; 2023 Feb; 62(1):103521. PubMed ID: 35941021
    [No Abstract]   [Full Text] [Related]  

  • 12. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
    Lung T; Sakem B; Risch M; Nydegger U
    Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19.
    Zahra FT; Bellusci L; Grubbs G; Golding H; Khurana S
    Ann Rheum Dis; 2022 Jul; 81(7):1044-1045. PubMed ID: 35144925
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on "Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection".
    Lutchi K; Jackson CD
    South Med J; 2023 May; 116(5):434. PubMed ID: 37137480
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.
    Sanfilippo F; La Rosa V; Oliveri F; Astuto M
    Am J Respir Crit Care Med; 2021 Jan; 203(2):257-258. PubMed ID: 33085908
    [No Abstract]   [Full Text] [Related]  

  • 17. Convalescent plasma therapy in patients with COVID-19.
    Altuntas F; Yigenoglu TN; Bascı S; Dal MS; Korkmaz S; Turgut B; Erkurt MA
    Transfus Apher Sci; 2021 Feb; 60(1):103017. PubMed ID: 33277207
    [No Abstract]   [Full Text] [Related]  

  • 18. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donating convalescent plasma for COVID-19 patients.
    Black E
    Br Dent J; 2020 Nov; 229(10):643. PubMed ID: 33247247
    [No Abstract]   [Full Text] [Related]  

  • 20. Convalescent plasma (CP) therapy in patients with COVID-19.
    Cakir B
    Transfus Apher Sci; 2021 Feb; 60(1):103018. PubMed ID: 33257204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 53.